Wells Fargo
FPRX

Wells Fargo’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-135,195
Closed -$5.09M 7467
2021
Q1
$5.09M Sell
135,195
-339,659
-72% -$12.8M ﹤0.01% 2698
2020
Q4
$8.08M Buy
474,854
+304,557
+179% +$5.18M ﹤0.01% 2273
2020
Q3
$801K Buy
170,297
+125,213
+278% +$589K ﹤0.01% 3929
2020
Q2
$275K Buy
45,084
+11,827
+36% +$72.1K ﹤0.01% 4569
2020
Q1
$76K Buy
33,257
+4,685
+16% +$10.7K ﹤0.01% 4988
2019
Q4
$131K Sell
28,572
-43,210
-60% -$198K ﹤0.01% 4992
2019
Q3
$278K Sell
71,782
-7,453
-9% -$28.9K ﹤0.01% 4609
2019
Q2
$478K Sell
79,235
-17,673
-18% -$107K ﹤0.01% 4299
2019
Q1
$1.3M Buy
96,908
+3,532
+4% +$47.3K ﹤0.01% 3664
2018
Q4
$868K Sell
93,376
-134,978
-59% -$1.25M ﹤0.01% 3860
2018
Q3
$3.18M Sell
228,354
-12,792
-5% -$178K ﹤0.01% 2989
2018
Q2
$3.81M Buy
241,146
+4,781
+2% +$75.6K ﹤0.01% 2904
2018
Q1
$4.06M Buy
236,365
+49,068
+26% +$843K ﹤0.01% 2778
2017
Q4
$4.11M Buy
187,297
+1,915
+1% +$42K ﹤0.01% 2732
2017
Q3
$7.58M Buy
185,382
+7,294
+4% +$298K ﹤0.01% 2172
2017
Q2
$5.36M Sell
178,088
-7,178
-4% -$216K ﹤0.01% 2368
2017
Q1
$6.7M Buy
185,266
+29,701
+19% +$1.07M ﹤0.01% 2186
2016
Q4
$7.8M Sell
155,565
-1,980
-1% -$99.2K ﹤0.01% 2037
2016
Q3
$8.27M Buy
157,545
+11,111
+8% +$583K ﹤0.01% 1878
2016
Q2
$6.05M Sell
146,434
-111
-0.1% -$4.59K ﹤0.01% 2166
2016
Q1
$5.95M Buy
146,545
+30,057
+26% +$1.22M ﹤0.01% 2170
2015
Q4
$4.83M Sell
116,488
-2,179
-2% -$90.4K ﹤0.01% 2334
2015
Q3
$1.83M Sell
118,667
-31,183
-21% -$480K ﹤0.01% 3015
2015
Q2
$3.72M Buy
149,850
+42,007
+39% +$1.04M ﹤0.01% 2615
2015
Q1
$2.47M Sell
107,843
-22,612
-17% -$517K ﹤0.01% 2863
2014
Q4
$3.52M Sell
130,455
-24,357
-16% -$658K ﹤0.01% 2581
2014
Q3
$1.82M Buy
154,812
+3,079
+2% +$36.1K ﹤0.01% 3040
2014
Q2
$2.36M Sell
151,733
-2,063
-1% -$32.1K ﹤0.01% 2881
2014
Q1
$3.02M Buy
153,796
+108,539
+240% +$2.13M ﹤0.01% 2680
2013
Q4
$760K Buy
+45,257
New +$760K ﹤0.01% 3557